Error: Could not add to watchlist. X

Selectra Investment SICAV - J LaMarck Biotech

+ Watchlist
SELJLBB:LX
278.27
EUR
0.30
0.11%
As of 00:59:30 ET on 07/02/2015.
Volume
0
Previous Close
277.97
52Wk Range
172.61 - 301.55
1 Yr Return
46.52%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
278.27
Total Assets (m EUR) (on 07/02/2015)
79.933
Inception Date
01/26/2011
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
-
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Amgen Inc 53.99 k 7.57 m 9.80
Gilead Sciences Inc 76.63 k 6.87 m 8.90
Isis Pharmaceuticals Inc 119.05 k 6.02 m 7.80
Vertex Pharmaceuticals Inc 42.52 k 4.67 m 6.05
Swedish Orphan Biovitrum AB 319.66 k 4.58 m 5.93
Profile
SELECTRA Investment SICAV - J.Lamarck Biotech is an open-end fund incorporated in Luxembourg. The objective of the Fund is to profit from increasing share prices in the biotechnology sector. The Fund will focus on mature top tier pharmaceutical biotech companies and companies with an interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE.
ADDRESS
Selectra Management Company
9 rue Schiller
L2519 Luxembourg
PHONE
Tel. +352 26 20 22 81